Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brigida Anna Maiorano
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma
Frontiers in Oncology
Cancer Research
Oncology
Related publications
Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAF Mutant Malignant Melanoma
Oncologist
Cancer Research
Medicine
Oncology
Optimizing Combination Dabrafenib and Trametinib Therapy in BRAF Mutation-Positive Advanced Melanoma Patients: Guidelines From Australian Melanoma Medical Oncologists
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Improved Overall Survival in Melanoma With Combined Dabrafenib and Trametinib
New England Journal of Medicine
Medicine
BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade With Dabrafenib, Trametinib, and Panitumumab in Patients With Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Redifferentiation of Iodine-Refractory BRAF V600e-Mutant Metastatic Papillary Thyroid Cancer With Dabrafenib
Clinical Cancer Research
Cancer Research
Oncology
Detection of Mutant BRAF Alleles in the Plasma of Patients With Metastatic Melanoma
Journal of Molecular Diagnostics
Forensic Medicine
Pathology
Molecular Medicine
Granulomatosis With Polyangiitis in a Patient Treated With Dabrafenib and Trametinib for BRAF V600E Positive Lung Adenocarcinoma
BMC Cancer
Cancer Research
Oncology
Genetics
PCN87 Cost Effectiveness Evaluation of Vemurafenib, an Orphan Drug for Braf Mutant Metastatic Melanoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Murine Model for Metastatic Conjunctival Melanoma
Investigative Ophthalmology and Visual Science
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
